272 related articles for article (PubMed ID: 19646263)
1. Depletion of intrinsic expression of Interleukin-8 in prostate cancer cells causes cell cycle arrest, spontaneous apoptosis and increases the efficacy of chemotherapeutic drugs.
Singh RK; Lokeshwar BL
Mol Cancer; 2009 Jul; 8():57. PubMed ID: 19646263
[TBL] [Abstract][Full Text] [Related]
2. CXC receptor-1 silencing inhibits androgen-independent prostate cancer.
Shamaladevi N; Lyn DA; Escudero DO; Lokeshwar BL
Cancer Res; 2009 Nov; 69(21):8265-74. PubMed ID: 19861539
[TBL] [Abstract][Full Text] [Related]
3. Chemotherapy-induced CXC-chemokine/CXC-chemokine receptor signaling in metastatic prostate cancer cells confers resistance to oxaliplatin through potentiation of nuclear factor-kappaB transcription and evasion of apoptosis.
Wilson C; Purcell C; Seaton A; Oladipo O; Maxwell PJ; O'Sullivan JM; Wilson RH; Johnston PG; Waugh DJ
J Pharmacol Exp Ther; 2008 Dec; 327(3):746-59. PubMed ID: 18780829
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-8 signaling promotes translational regulation of cyclin D in androgen-independent prostate cancer cells.
MacManus CF; Pettigrew J; Seaton A; Wilson C; Maxwell PJ; Berlingeri S; Purcell C; McGurk M; Johnston PG; Waugh DJ
Mol Cancer Res; 2007 Jul; 5(7):737-48. PubMed ID: 17606477
[TBL] [Abstract][Full Text] [Related]
5. CDK inhibitors induce mitochondria-mediated apoptosis through the activation of polyamine catabolic pathway in LNCaP, DU145 and PC3 prostate cancer cells.
Arisan ED; Obakan P; Coker-Gurkan A; Calcabrini A; Agostinelli E; Unsal NP
Curr Pharm Des; 2014; 20(2):180-8. PubMed ID: 23701543
[TBL] [Abstract][Full Text] [Related]
6. Myb overexpression overrides androgen depletion-induced cell cycle arrest and apoptosis in prostate cancer cells, and confers aggressive malignant traits: potential role in castration resistance.
Srivastava SK; Bhardwaj A; Singh S; Arora S; McClellan S; Grizzle WE; Reed E; Singh AP
Carcinogenesis; 2012 Jun; 33(6):1149-57. PubMed ID: 22431717
[TBL] [Abstract][Full Text] [Related]
7. Resveratrol induces cell cycle arrest and apoptosis with docetaxel in prostate cancer cells via a p53/ p21WAF1/CIP1 and p27KIP1 pathway.
Singh SK; Banerjee S; Acosta EP; Lillard JW; Singh R
Oncotarget; 2017 Mar; 8(10):17216-17228. PubMed ID: 28212547
[TBL] [Abstract][Full Text] [Related]
8. L-securinine inhibits cell growth and metastasis of human androgen-independent prostate cancer DU145 cells via regulating mitochondrial and AGTR1/MEK/ERK/STAT3/PAX2 apoptotic pathways.
Zhang D; Liu H; Yang B; Hu J; Cheng Y
Biosci Rep; 2019 May; 39(5):. PubMed ID: 30975734
[TBL] [Abstract][Full Text] [Related]
9. FAM3B/PANDER inhibits cell death and increases prostate tumor growth by modulating the expression of Bcl-2 and Bcl-X
Maciel-Silva P; Caldeira I; de Assis Santos I; Carreira ACO; Siqueira FR; Antonioli E; Goldberg AC; Belizário JE; Garay-Malpartida HM
BMC Cancer; 2018 Jan; 18(1):90. PubMed ID: 29357840
[TBL] [Abstract][Full Text] [Related]
10. Veratramine Inhibits the Cell Cycle Progression, Migration, and Invasion via ATM/ATR Pathway in Androgen-Independent Prostate Cancer.
Kim HY; Lee SW; Choi SK; Ashim J; Kim W; Beak SM; Park JK; Han JE; Cho GJ; Ryoo ZY; Jeong J; Lee YH; Jeong H; Yu W; Park S
Am J Chin Med; 2023; 51(5):1309-1333. PubMed ID: 37385965
[TBL] [Abstract][Full Text] [Related]
11. The depletion of interleukin-8 causes cell cycle arrest and increases the efficacy of docetaxel in breast cancer cells.
Shao N; Chen LH; Ye RY; Lin Y; Wang SM
Biochem Biophys Res Commun; 2013 Feb; 431(3):535-41. PubMed ID: 23321310
[TBL] [Abstract][Full Text] [Related]
12. Combination of ginsenoside Rg3 with docetaxel enhances the susceptibility of prostate cancer cells via inhibition of NF-kappaB.
Kim SM; Lee SY; Cho JS; Son SM; Choi SS; Yun YP; Yoo HS; Yoon DY; Oh KW; Han SB; Hong JT
Eur J Pharmacol; 2010 Apr; 631(1-3):1-9. PubMed ID: 20056115
[TBL] [Abstract][Full Text] [Related]
13. Anti-androgen-independent prostate cancer effects of ginsenoside metabolites in vitro: mechanism and possible structure-activity relationship investigation.
Li W; Liu Y; Zhang JW; Ai CZ; Xiang N; Liu HX; Yang L
Arch Pharm Res; 2009 Jan; 32(1):49-57. PubMed ID: 19183876
[TBL] [Abstract][Full Text] [Related]
14. Persistent p21Cip1 induction mediates G(1) cell cycle arrest by methylseleninic acid in DU145 prostate cancer cells.
Wang Z; Lee HJ; Chai Y; Hu H; Wang L; Zhang Y; Jiang C; Lü J
Curr Cancer Drug Targets; 2010 May; 10(3):307-18. PubMed ID: 20370687
[TBL] [Abstract][Full Text] [Related]
15. Interferon inducible antiviral MxA is inversely associated with prostate cancer and regulates cell cycle, invasion and Docetaxel induced apoptosis.
Brown SG; Knowell AE; Hunt A; Patel D; Bhosle S; Chaudhary J
Prostate; 2015 Feb; 75(3):266-79. PubMed ID: 25327819
[TBL] [Abstract][Full Text] [Related]
16. Antisense RNA down-regulation of bcl-xL Expression in prostate cancer cells leads to diminished rates of cellular proliferation and resistance to cytotoxic chemotherapeutic agents.
Vilenchik M; Raffo AJ; Benimetskaya L; Shames D; Stein CA
Cancer Res; 2002 Apr; 62(7):2175-83. PubMed ID: 11929841
[TBL] [Abstract][Full Text] [Related]
17. Natural proteasome inhibitor celastrol suppresses androgen-independent prostate cancer progression by modulating apoptotic proteins and NF-kappaB.
Dai Y; Desano J; Tang W; Meng X; Meng Y; Burstein E; Lawrence TS; Xu L
PLoS One; 2010 Dec; 5(12):e14153. PubMed ID: 21170316
[TBL] [Abstract][Full Text] [Related]
18. Antitumor activity of hyaluronic acid synthesis inhibitor 4-methylumbelliferone in prostate cancer cells.
Lokeshwar VB; Lopez LE; Munoz D; Chi A; Shirodkar SP; Lokeshwar SD; Escudero DO; Dhir N; Altman N
Cancer Res; 2010 Apr; 70(7):2613-23. PubMed ID: 20332231
[TBL] [Abstract][Full Text] [Related]
19. Small-interfering RNA-induced androgen receptor silencing leads to apoptotic cell death in prostate cancer.
Liao X; Tang S; Thrasher JB; Griebling TL; Li B
Mol Cancer Ther; 2005 Apr; 4(4):505-15. PubMed ID: 15827323
[TBL] [Abstract][Full Text] [Related]
20. Effect of AQP9 Expression in Androgen-Independent Prostate Cancer Cell PC3.
Chen Q; Zhu L; Zheng B; Wang J; Song X; Zheng W; Wang L; Yang D; Wang J
Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27187384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]